The mutual binding of CXCL8 to CXCR2 activates downstream signaling pathways and enhances the invasiveness of various tumors, including hepatocellular carcinoma (HCC), making it a potential therapeutic target. Here, CXCL8 is linked to hepatocellular carcinoma.